These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8021689)

  • 1. Familial Parkinson's disease and polymorphism at the CYP2D6 locus.
    Mazzetti P; Le Guern E; Bonnet AM; Vidailhet M; Brice A; Agid Y
    J Neurol Neurosurg Psychiatry; 1994 Jul; 57(7):871-2. PubMed ID: 8021689
    [No Abstract]   [Full Text] [Related]  

  • 2. Gene-environment interaction in parkinson's disease. The case of CYP2D6 gene polymorphism.
    Landi MT; Ceroni M; Martignoni E; Bertazzi PA; Caporaso NE; Nappi G
    Adv Neurol; 1996; 69():61-72. PubMed ID: 8615186
    [No Abstract]   [Full Text] [Related]  

  • 3. Debrisoquine hydroxylase gene polymorphism in familial Parkinson's disease.
    Planté-Bordeneuve V; Davis MB; Maraganore DM; Marsden CD; Harding AE
    J Neurol Neurosurg Psychiatry; 1994 Aug; 57(8):911-3. PubMed ID: 8057112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease.
    Smith CA; Gough AC; Leigh PN; Summers BA; Harding AE; Maraganore DM; Sturman SG; Schapira AH; Williams AC
    Lancet; 1992 Jun; 339(8806):1375-7. PubMed ID: 1350805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP2D6-debrisoquine hydroxylase gene polymorphism in multiple system atrophy.
    Planté-Bordeneuve V; Bandmann O; Wenning G; Quinn NP; Daniel SE; Harding AE
    Mov Disord; 1995 May; 10(3):277-8. PubMed ID: 7651442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Debrisoquine hydroxylation genotype in familial forms of idiopathic Parkinson's disease.
    Bordet R; Broly F; Destée A; Libersa C
    Adv Neurol; 1996; 69():97-100. PubMed ID: 8615190
    [No Abstract]   [Full Text] [Related]  

  • 7. A novel cytochrome P-450IID6 (CYPIID6) mutant gene associated with multiple system atrophy.
    Iwahashi K; Miyatake R; Tsuneoka Y; Matsuo Y; Ichikawa Y; Hosokawa K; Sato K; Hayabara T
    J Neurol Neurosurg Psychiatry; 1995 Feb; 58(2):263-4. PubMed ID: 7876880
    [No Abstract]   [Full Text] [Related]  

  • 8. Mutant debrisoquine hydroxylation genes in Parkinson's disease.
    Armstrong M; Daly AK; Cholerton S; Bateman DN; Idle JR
    Lancet; 1992 Apr; 339(8800):1017-8. PubMed ID: 1349052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel cytochrome P-450IID6 mutant gene associated with Parkinson's disease.
    Tsuneoka Y; Matsuo Y; Iwahashi K; Takeuchi H; Ichikawa Y
    J Biochem; 1993 Aug; 114(2):263-6. PubMed ID: 7903297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between the oxidative polymorphism and early onset of Parkinson's disease.
    Agúndez JA; Jiménez-Jiménez FJ; Luengo A; Bernal ML; Molina JA; Ayuso L; Vázquez A; Parra J; Duarte J; Coria F
    Clin Pharmacol Ther; 1995 Mar; 57(3):291-8. PubMed ID: 7697946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Debrisoquine hydroxylase and Parkinson's disease.
    Kondo I; Kanazawa I
    Adv Neurol; 1993; 60():338-42. PubMed ID: 8420147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arg296 to Cys296 polymorphism in exon 6 of cytochrome P-450-2D6 (CYP2D6) is not associated with multiple system atrophy.
    Bandmann O; Wenning GK; Quinn NP; Harding AE
    J Neurol Neurosurg Psychiatry; 1995 Nov; 59(5):557. PubMed ID: 8530951
    [No Abstract]   [Full Text] [Related]  

  • 13. CYP2D6 allelic frequencies in young-onset Parkinson's disease.
    Sandy MS; Armstrong M; Tanner CM; Daly AK; Di Monte DA; Langston JW; Idle JR
    Neurology; 1996 Jul; 47(1):225-30. PubMed ID: 8710083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dinucleotide repeat polymorphism at the human debrisoquine 4-hydroxylase (CYP2D) locus.
    Polymeropoulos MH; Rath DS; Xiao H; Merril CR
    Nucleic Acids Res; 1991 Apr; 19(8):1961. PubMed ID: 2030982
    [No Abstract]   [Full Text] [Related]  

  • 15. A polymorphic CfoI site in exon 6 of the human cytochrome P450 CYP2D6 gene detected by the polymerase chain reaction.
    Armstrong M; Idle JR; Daly AK
    Hum Genet; 1993 Jul; 91(6):616-7. PubMed ID: 8340116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic polymorphism of drug metabolizing enzymes].
    Yokoi T; Kamataki T
    Seikagaku; 1997 Oct; 69(10):1196-9. PubMed ID: 9431010
    [No Abstract]   [Full Text] [Related]  

  • 17. Dinucleotide repeat polymorphism at the debrisoquine 4-hydroxylase (CYP2D) locus.
    Trofatter JA; Gusella JF; Haines JL
    Nucleic Acids Res; 1991 May; 19(10):2802. PubMed ID: 2041763
    [No Abstract]   [Full Text] [Related]  

  • 18. Lack association between schizophrenia and the CYP2D6 gene polymorphisms.
    Pirmohamed M; Wild MJ; Kitteringham NR; O'Brien K; Buchan IE; Back DJ; Park BK
    Am J Med Genet; 1996 Apr; 67(2):236-7. PubMed ID: 8723057
    [No Abstract]   [Full Text] [Related]  

  • 19. Neurogenetic correlates of Parkinson's disease: apolipoprotein-E and cytochrome P450 2D6 genetic polymorphism.
    Bon MA; Jansen Steur EN; de Vos RA; Vermes I
    Neurosci Lett; 1999 May; 266(2):149-51. PubMed ID: 10353349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poor metabolisers of nicotine and CYP2D6 polymorphism.
    Cholerton S; Arpanahi A; McCracken N; Boustead C; Taber H; Johnstone E; Leathart J; Daly AK; Idle JR
    Lancet; 1994 Jan; 343(8888):62-3. PubMed ID: 7905082
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.